Hummelstown, PA, United States of America

Jong K Yun

This inventor holds 1 USPTO granted patent. Top assignee: The Penn State Research Foundation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong K Yun. Retrieved from https://idiyas.com/inventor/jong-k-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong K Yun: Innovator in Sphingosine Kinase Inhibition

Introduction: Jong K Yun is a notable inventor based in Hummelston, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of sphingosine kinase inhibitors. His work focuses on developing compositions and methods for inhibiting sphingosine kinase, which is crucial for treating hyperproliferative diseases.

Latest Patents: Jong K Yun holds 1 patent related to his innovative work. His patent, titled "Sphingosine kinase inhibitors," outlines the methods and compositions that can effectively inhibit sphingosine kinase, providing potential therapeutic avenues for various diseases.

Career Highlights: Jong K Yun is affiliated with The Pennsylvania State University Research Foundation, where he conducts his research and development activities. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations: Throughout his career, Jong K Yun has worked alongside notable colleagues, including Charles D Smith and Kevin J French. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion: Jong K Yun's contributions to the field of sphingosine kinase inhibition highlight his innovative spirit and dedication to advancing medical science. His work has the potential to lead to significant advancements in the treatment of hyperproliferative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…